Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rivabazumab pegol, a pegylated Fab antibody targeting the PcrV protein, is utilized in phase II studies for chronic Pseudomonas aeruginosa infections [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Rivabazumab pegol, a pegylated Fab antibody targeting the PcrV protein, is utilized in phase II studies for chronic Pseudomonas aeruginosa infections [1]. |
Molecular Weight | N/A |
CAS No. | 1613506-32-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rivabazumab pegol 1613506-32-3 inhibitor inhibit